KCM
KURA icon

Kennedy Capital Management’s Kura Oncology KURA Stock Holding History

Kennedy Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-113,715
Closed -$1.64M – 752
2023
Q4 		$1.64M Buy
113,715
+34,197
+43% +$336K 0.04% 527
2023
Q3 		$725K Hold
79,518
– – 0.02% 592
2023
Q2 		$841K Hold
79,518
– – 0.02% 567
2023
Q1 		$973K Buy
79,518
+51,123
+180% +$638K 0.03% 490
2022
Q4 		$352K Buy
+28,395
New +$413K 0.01% 577
2021
Q1 		– Sell
-56,838
Closed -$1.86M – 687
2020
Q4 		$1.86M Sell
56,838
-43,355
-43% -$1.52M 0.04% 514
2020
Q3 		$3.07M Sell
100,193
-413
-0.4% -$9.12K 0.09% 413
2020
Q2 		$1.64M Sell
100,606
-4,476
-4% -$64.6K 0.05% 530
2020
Q1 		$1.05M Sell
105,082
-4,383
-4% -$50.2K 0.04% 553
2019
Q4 		$1.5M Sell
109,465
-4,879
-4% -$72.3K 0.04% 580
2019
Q3 		$1.74M Sell
114,344
-7,143
-6% -$127K 0.04% 550
2019
Q2 		$2.39M Sell
121,487
-150,572
-55% -$2.5M 0.06% 507
2019
Q1 		$4.51M Sell
272,059
-34,361
-11% -$529K 0.11% 358
2018
Q4 		$4.3M Sell
306,420
-79,453
-21% -$1.05M 0.11% 359
2018
Q3 		$6.75M Buy
385,873
+288,579
+297% +$5.53M 0.13% 299
2018
Q2 		$1.77M Buy
+97,294
New +$1.65M 0.03% 612

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Kennedy Capital Management's KURA Position: Q1 2024 in Review

Kennedy Capital Management sold out of Kura Oncology (KURA) in Q1 2024, closing a stake of 113,715 shares — an estimated $1.64M sold.

Kennedy Capital Management first reported a position in KURA in Q2 2018 and held it in 16 quarters. The position peaked at $6.75M in Q3 2018. 165 funds tracked by Wall St. Rank hold KURA as of Q1 2024.

  • Kennedy Capital Management reported no remaining Kura Oncology position as of Q1 2024 after selling out during the quarter.
  • Kennedy Capital Management sold 113,715 Kura Oncology shares in Q1 2024, an estimated $1.64M.
  • Kennedy Capital Management first reported a position in Kura Oncology in Q2 2018 and held it in 16 quarters.
  • Kennedy Capital Management's Kura Oncology position peaked at $6.75M in Q3 2018.
  • 165 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2024.

Based on Kennedy Capital Management's 13F filing for Q1 2024, filed 15 May 2024.